It is considered a related intermediate or building block in the production of this Janus kinase (JAK) inhibitor, which is used to treat myelofibrosis, polycythemia vera, and graft-versus-host disease. (Triphenylphosphoranylidene)acetaldehyde (CAS 2136-75-6) serves as a reagent in the pharmaceutical industry for the synthesis of Ruxolitinib.
(Triphenylphosphoranylidene)acetaldehyde
| API Name | Ruxolitinib |
|---|---|
| CAS No | 2136-75-6 |
| Molecular Formula | C20H17OP |
| Molecular Weight | 304.3 g/mol |
| Synonyms | 2-(triphenyl-λ5-phosphanylidene)acetaldehyde |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
It is considered a related intermediate or building block in the production of this Janus kinase (JAK) inhibitor, which is used to treat myelofibrosis, polycythemia vera, and graft-versus-host disease. (Triphenylphosphoranylidene)acetaldehyde (CAS 2136-75-6) serves as a reagent in the pharmaceutical industry for the synthesis of Ruxolitinib.
The CAS number of (Triphenylphosphoranylidene)acetaldehyde is 2136-75-6.
The molecular formula of (Triphenylphosphoranylidene)acetaldehyde is C20H17OP.
The listed molecular weight of (Triphenylphosphoranylidene)acetaldehyde is 304.3 g/mol.
(Triphenylphosphoranylidene)acetaldehyde is listed as being used in connection with the following API: Ruxolitinib.
The listed synonym or IUPAC name for (Triphenylphosphoranylidene)acetaldehyde is 2-(triphenyl-λ5-phosphanylidene)acetaldehyde.